Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer.

ABSTRACT:

SUBMITTER: Mair MJ 

PROVIDER: S-EPMC9501743 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature